scholarly journals Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: a phase II, multicentre, randomized, vehicle-controlled clinical study

2018 ◽  
Vol 178 (2) ◽  
pp. 424-432 ◽  
Author(s):  
H. Nakagawa ◽  
O. Nemoto ◽  
A. Igarashi ◽  
T. Nagata
Keyword(s):  
Atopic Dermatitis ◽  
Clinical Study ◽  
Phase Ii ◽  
Kinase Inhibitor ◽  
Janus Kinase ◽  
Severe Atopic Dermatitis ◽  
Efficacy And Safety ◽  
Japanese Adult ◽  
Janus Kinase Inhibitor ◽  
Controlled Clinical Study

scholarly journals Long‐term safety and efficacy of delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with atopic dermatitis

2019 ◽  
Vol 47 (2) ◽  
pp. 114-120 ◽  
Author(s):  
Hidemi Nakagawa ◽  
Osamu Nemoto ◽  
Atsuyuki Igarashi ◽  
Hidehisa Saeki ◽  
Ryusei Murata ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Kinase Inhibitor ◽  
Janus Kinase ◽  
Adult Patients ◽  
Janus Kinase Inhibitor ◽  
Safety And Efficacy

Tofacitinib, an oral Janus kinase inhibitor, in patients from Mexico with rheumatoid arthritis: Pooled efficacy and safety analyses from Phase 3 and LTE studies

2019 ◽  
Vol 15 (1) ◽  
pp. 43-53
Author(s):  
Ruben Burgos-Vargas ◽  
Mario Cardiel ◽  
Daniel Xibillèc) ◽  
Cèc)sar Pacheco-Tena ◽  
Virginia Pascual-Ramos ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Kinase Inhibitor ◽  
Janus Kinase ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Janus Kinase Inhibitor
Sign in / Sign up

Export Citation Format

Share Document